These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14636713)

  • 21. Evaluation of antiviral activity and toxicity of recombinant human interferon alfa-2a in calves persistently infected with type 1 bovine viral diarrhea virus.
    Peek SF; Bonds MD; Schaele P; Weber S; Friedrichs K; Schultz RD
    Am J Vet Res; 2004 Jun; 65(6):865-70. PubMed ID: 15198230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New antibody immobilization method via functional liposome layer for specific protein assays.
    Lee HY; Jung HS; Fujikawa K; Park JW; Kim JM; Yukimasa T; Sugihara H; Kawai T
    Biosens Bioelectron; 2005 Nov; 21(5):833-8. PubMed ID: 16242625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection.
    Itri LM; Campion M; Dennin RA; Palleroni AV; Gutterman JU; Groopman JE; Trown PW
    Cancer; 1987 Feb; 59(3 Suppl):668-74. PubMed ID: 10822468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of neutralizing antibodies to interferon in condyloma acuminata and cancer patients treated with natural human leukocyte interferon.
    Liao MJ; Axelrod HR; Kuchler M; Yip YK; Kirkbright E; Testa D
    J Infect Dis; 1992 Apr; 165(4):757-60. PubMed ID: 1552208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of neutralizing antibodies to human type I interferons using division-arrested frozen cells carrying an interferon-regulated reporter-gene.
    Lallemand C; Meritet JF; Erickson R; Grossberg SE; Roullet E; Lyon-Caen O; Lebon P; Tovey MG
    J Interferon Cytokine Res; 2008 Jun; 28(6):393-404. PubMed ID: 18593334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon alpha2b augments suppressed immune functions in tobacco-related head and neck squamous cell carcinoma patients by modulating cytokine signaling.
    Bose A; Ghosh D; Pal S; Mukherjee KK; Biswas J; Baral R
    Oral Oncol; 2006 Feb; 42(2):161-71. PubMed ID: 16249117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein array-based multiplexed cytokine assays.
    Wang CC
    Methods Mol Biol; 2007; 385():177-92. PubMed ID: 18365712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-chip protein arrays: force-based multiplex sandwich immunoassays with increased specificity.
    Blank K; Lankenau A; Mai T; Schiffmann S; Gilbert I; Hirler S; Albrecht C; Benoit M; Gaub HE; Clausen-Schaumann H
    Anal Bioanal Chem; 2004 Aug; 379(7-8):974-81. PubMed ID: 15103448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of human serum leptin using a nanoarray protein chip based on single-molecule sandwich immunoassay.
    Lee S; Lee S; Ko YH; Jung H; Kim JD; Song JM; Choo J; Eo SK; Kang SH
    Talanta; 2009 Apr; 78(2):608-12. PubMed ID: 19203632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ELISA methods for the analysis of antibody responses induced in multiple sclerosis patients treated with recombinant interferon-beta.
    Brickelmaier M; Hochman PS; Baciu R; Chao B; Cuervo JH; Whitty A
    J Immunol Methods; 1999 Jul; 227(1-2):121-35. PubMed ID: 10485260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D protein microarrays: performing multiplex immunoassays on a single chip.
    Angenendt P; Glökler J; Konthur Z; Lehrach H; Cahill DJ
    Anal Chem; 2003 Sep; 75(17):4368-72. PubMed ID: 14632038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuning the setup of sputter-coated multilayers in nanocluster-based signal-enhancing biochips for optimal performance in protein and DNA assays.
    Matyushin V; Gandhum A; Stich N; Schalkhammer T; Hagen WR; Mayer C
    J Nanosci Nanotechnol; 2004; 4(1-2):98-105. PubMed ID: 15112550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different specificities of SLE-derived and therapy-induced interferon-alpha antibodies.
    Nolte KU; Jakschies D; Pestka S; Von Wussow P
    J Interferon Res; 1994 Aug; 14(4):197-9. PubMed ID: 7822874
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of neutralizing interferon antibodies after treatment with recombinant interferon-alpha 2b in patients with malignant carcinoid tumors.
    Oberg K; Alm GV
    J Interferon Res; 1989 Sep; 9 Suppl 1():S45-9. PubMed ID: 2809277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction, expression and characterization of human interferon alpha2b-(G4S)n-thymosin alpha1 fusion proteins in Pichia pastoris.
    Yang YF; Yuan HY; Liu NS; Chen XL; Gao BY; Lu H; Li YY
    World J Gastroenterol; 2005 May; 11(17):2597-602. PubMed ID: 15849818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study.
    Ducreux J; Houssiau FA; Vandepapelière P; Jorgensen C; Lazaro E; Spertini F; Colaone F; Roucairol C; Laborie M; Croughs T; Grouard-Vogel G; Lauwerys BR
    Rheumatology (Oxford); 2016 Oct; 55(10):1901-5. PubMed ID: 27354683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity.
    Oberg K; Alm G; Magnusson A; Lundqvist G; Theodorsson E; Wide L; Wilander E
    J Natl Cancer Inst; 1989 Apr; 81(7):531-5. PubMed ID: 2466128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-alpha interferon antibodies after alpha interferon treatment in patients with chronic viral hepatitis.
    Craxi A; Di Marco V; Volpes R; Palazzo U
    Hepatogastroenterology; 1988 Dec; 35(6):304-5. PubMed ID: 3063647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of N-succinimidyl 4-(maleimidomethyl) cyclohexanecarboxylate (SMCC) modified biochip enabling concurrent detection of serum infectious antibodies in neuroborreliosis.
    Ye L; Huang NL; Ma XL; Schneider M; Huang XJ; Du WD
    Biosens Bioelectron; 2016 Apr; 78():404-410. PubMed ID: 26655180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus.
    Mathian A; Amoura Z; Adam E; Colaone F; Hoekman MF; Dhellin O; Vandepapelière P; Haroche J; Piette JC; Lebon P; Grouard-Vogel G
    Ann Rheum Dis; 2011 Jun; 70(6):1138-43. PubMed ID: 21389044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.